Scleral Versus Corneal RGP Contact Lenses in Irregular Cornea Disorders
A Randomised Controlled Research to Asses the Clinical Performance and Effect on Vision Related Quality of Life of Rigid Gas Permeable Scleral Versus Corneal Contact Lenses for Keratoconus and Other Irregular Cornea Disorders
1 other identifier
interventional
30
1 country
1
Brief Summary
The most common causes for irregular cornea (IC) in hospital contact lens practice are Keratoconus (KC) and related cornea thinning disorders. These conditions cause mild to marked impairment of vision and cannot be effectively corrected by spectacles and soft contact lenses. The gold standard in the management of KC is Corneal Rigid Gas Permeable contact lenses (corneal lenses), which correct approximately 90% of the corneal irregularity. Compared with a normal cornea, the cornea in KC is irregular and this results in a compromise to the fit of rigid corneal lenses. Specifically, they bear on the cornea and this, together with the vulnerability of the cornea in KC, are implicated in corneal scarring, and disease progression as well as a significantly reduced vision related quality of life (QoL) in KC compared with corneal lens wearers who have no KC. In cases where the compromise fit of corneal lenses proves problematic, large diameter Scleral RGP contact lenses (scleral lenses) may be used as a problem solver. Unlike the smaller corneal lenses which bear on the cornea, the scleral lenses completely bridge over the cornea and bear on the sclera. The aim of this research is to investigate the performance of scleral lenses in KC participants who habitually wear corneal lenses. The research question: is there a measurable difference in the visual performance and visual quality of life in participants with Irregular cornea disorders like keratoconus and other related conditions, who habitually wear corneal lenses in comparison with scleral lenses.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2015
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 21, 2015
CompletedFirst Posted
Study publicly available on registry
May 15, 2015
CompletedStudy Start
First participant enrolled
October 25, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 29, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
January 29, 2019
CompletedAugust 19, 2019
August 1, 2019
3.3 years
April 21, 2015
August 16, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Monocular Best Corrected Visual Acuity (BCVA)
High contrast BCVA will be measured by the specially constructed crowded, Logarithmic Minimum Angle of Resolution (LogMAR), Early Treatment Diabetic Retinopathy Survey (ETDRS) letter charts. An average score of 3 different, randomly presented charts will be taken as the final acuity score. It will be performed utilising the CSV1000E, under the established recommended standardised testing conditions utilised in a multitude of research protocols.
Baseline and after a minimum of 6 weeks of wear of each contact lens type, report at study completion
Secondary Outcomes (4)
Contrast Sensitivity Function
Measure at recruitment (Baseline), subsequent measurement after 6 weeks of wear, of lens 1 and 6 weeks of wear of lens 2. Study completion after 6-12 months.
The National Eye Institute-Visual Function Questionnaire (NEI-VFQ)
Measure at recruitment (Baseline), subsequent measurement after 6 weeks of wear, of lens 1 and 6 weeks of wear of lens 2. Study completion after 6-12 months.
The Levit Subjective Comfort and Vision Scales
Measure at recruitment (Baseline), subsequent measurement after 6 weeks of wear, of lens 1 and 6 weeks of wear of lens 2. Study completion after 6-12 months.
The final lens choice
At study completion after 6-12 months
Study Arms (2)
Scleral rigid gas permeable contact lenses
EXPERIMENTALThe experimental intervention is the Scleral Rigid Gas Permeable contact lens (SRGPcl), Zenlens™. These lenses are designed to bridge the cornea and fit in alignment with the sclera, thus avoiding any detrimental effects associated with corneal contact.
Corneal rigid gas permeable contact lenses
PLACEBO COMPARATORThe control intervention is the RoseK2™ Corneal Rigid Gas Permeable contact lens (CRGPcl). Corneal lenses are considered the gold standard in the management of the visual disability due to keratoconus and other related irregular cornea disorders.
Interventions
Custom manufactured scleral rigid gas permeable contact lenses. These lenses are designed to fit the eye with high level of precision. The aim is to bridge the cornea and fit in alignment with the sclera, thus avoiding any detrimental effects associated with the corneal rigid gas permeable lenses.
The Rose K2 lens is a widely used corneal gas permeable lens designed for keratoconus and other irregular cornea disorders
Eligibility Criteria
You may qualify if:
- Diagnosis of keratoconus or related corneal irregularity
- Age 18 years to 69 years.
You may not qualify if:
- Good visual quality with soft contact lenses and or spectacles
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Central Middlesex Hospital
London, NW10 7NS, United Kingdom
Related Publications (1)
Visser ES, Van der Linden BJ, Otten HM, Van der Lelij A, Visser R. Medical applications and outcomes of bitangential scleral lenses. Optom Vis Sci. 2013 Oct;90(10):1078-85. doi: 10.1097/OPX.0000000000000018.
PMID: 23974663RESULT
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alexander Levit, FCOptom
London South Bank Unversity
- STUDY DIRECTOR
Martin Benwell, PhD
London South Bank University
- STUDY CHAIR
Bruce Evans, PhD
Institute of Optometry
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Masking Details
- The practitioner who measures the visual outcomes is naive to the type of lens the participant is wearing
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 21, 2015
First Posted
May 15, 2015
Study Start
October 25, 2015
Primary Completion
January 29, 2019
Study Completion
January 29, 2019
Last Updated
August 19, 2019
Record last verified: 2019-08
Data Sharing
- IPD Sharing
- Will not share